Xu Tian
- Topics
- Cancer-related Molecular Pathways (4 papers)Mitochondrial Function and Pathology (3 papers)DNA Repair Mechanisms (2 papers)
- Journals
- Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xu Tian
20 papers receiving 374 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 233
- Cancer Research 88
- Oncology 57
- Immunology 47
- Epidemiology 45
Countries citing papers authored by Xu Tian
This map shows the geographic impact of Xu Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Tian more than expected).
Fields of papers citing papers by Xu Tian
This network shows the impact of papers produced by Xu Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Tian. The network helps show where Xu Tian may publish in the future.
Co-authorship network of co-authors of Xu Tian
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Tian. A scholar is included among the top collaborators of Xu Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Tian. Xu Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 22 | |
| 6 | 5 | |
| 7 | Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance | 1 |
| 8 | 39 | |
| 9 | 0 | |
| 10 | 18 | |
| 11 | 24 | |
| 12 | 9 | |
| 13 | 3 | |
| 14 | 8 | |
| 15 | 10 | |
| 16 | 24 | |
| 17 | 17 | |
| 18 | 49 | |
| 19 | 46 | |
| 20 | 71 |
About Xu Tian
Xu Tian is a scholar working on Cancer Research, Geriatrics and Gerontology and Immunology, having authored 23 papers that have together received 376 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Mitochondrial Function and Pathology (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Cancer Research (88 citations), Molecular Biology (233 citations) and Health, Toxicology and Mutagenesis (32 citations). Xu Tian has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Mian Wu, Youjun Chen, Shanshan Feng, Yiyi Huang, Klaus Heese, Li Ma, Mei Li, Xiao‐Bo Qiu, Wei Xie and Zhiyin Song. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.